You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy Trial (SHR-A1811,

Not yet recruiting
  • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
  • (no location specified)
Nov 7, 2023

Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in Brussels (Prospective data and sample collection,

Not yet recruiting
  • Early-stage Breast Cancer
  • Estrogen-receptor-positive Breast Cancer
  • Prospective data and sample collection
  • +2 more
  • Brussels, Belgium
    Imane Bachir
Nov 27, 2023

Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)

Recruiting
  • Breast Cancer
  • Capecitabine+endocrine therapy
  • Placebo+endocrine therapy
  • Zhengzhou, Henan, China
    Henan cancer hospital
Nov 19, 2022

Breast Cancer, Breast Tumor Trial in Philadelphia ([18F]ISO-1)

Active, not recruiting
  • Breast Cancer
  • Breast Neoplasm
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jan 17, 2023

Primary Breast Cancer Trial (SPECT)

Not yet recruiting
  • Primary Breast Cancer
  • (no location specified)
Jun 19, 2023

Breast Cancer Trial in Sheung Shui (Subpectoral plexus block (low dose), Subpectoral plexus block (High dose))

Not yet recruiting
  • Breast Cancer
  • Subpectoral plexus block (low dose)
  • Subpectoral plexus block (High dose)
  • Sheung Shui, New Territories, Hong Kong
    North District Hospital
Dec 5, 2022

Prognostic Significance of HER-2 Status Discordance Between

Completed
  • Breast Cancer
  • no intervention
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 19, 2022

Breast Cancer Trial in Philadelphia (BPET/DBT imaging, 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 12, 2022

TAD in Primary Breast Cancer With Initially = 3 Suspicious Lymph

Recruiting
  • Breast Cancer
  • Targeted axilllary dissection (TAD) followed by axillary lymph node dissection (ALND)
  • Essen, Germany
    Kliniken Essen-Mitte (KEM)
Jul 14, 2022

Rehabilitation, Breast Tumors, Psychological Distress Trial in Malmö (Individualised rehabilitation, Care as usual)

Recruiting
  • Rehabilitation
  • +2 more
  • Individualised rehabilitation
  • Care as usual
  • Malmö, Sweden
    Skåne university hospital
Apr 26, 2022

Breast Cancer, Lymph Node Metastases Trial in Boston (SpotTM Tattoo Ink)

Recruiting
  • Breast Cancer
  • Lymph Node Metastases
  • SpotTM Tattoo Ink
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 17, 2023

Breast Cancer Trial (CBD Oral, Control)

Not yet recruiting
  • Breast Cancer
  • CBD Oral
  • Control
  • (no location specified)
Nov 18, 2023

Shoulder Pain, Late Effect, Breast Cancer Trial in Vejle (The expert assessment of shoulder impairments and individualised

Completed
  • Shoulder Pain
  • +3 more
  • The expert assessment of shoulder impairments and individualised treatment plan
  • A minimal physiotherapeutic rehabilitation program delivered in a pamphlet
  • Vejle, Denmark
    Department of Physio- and Occupational Therapy, Vejle Hospital
Nov 2, 2022

Breast Cancer Trial in Charlottesville (Placebo, Lidocaine)

Completed
  • Breast Cancer
  • Charlottesville, Virginia
    University of Virginia Health System
Mar 9, 2022

Primary Breast Cancer Trial in Aachen (Application and measurement of tumor vascularization using diagnostic contrast enhanced

Recruiting
  • Primary Breast Cancer
  • Application and measurement of tumor vascularization using diagnostic contrast enhanced ultrasound (CEUS)
  • Aachen, NRW, Germany
    Department of Gynecology and Obstetrics Universitätsklinikum Aac
Jun 29, 2022

HER2-negative Breast Cancer Trial in Georgia, Mexico, United Kingdom (AZD9833)

Recruiting
  • HER2-negative Breast Cancer
  • Batumi, Georgia
  • +18 more
Jan 13, 2023

Breast Cancer Trial in New York (pHLIP® ICG NIRF imaging)

Recruiting
  • Breast Cancer
  • pHLIP® ICG NIRF imaging
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Jul 27, 2022

Delayed SLND for Breast Cancer Undergoing Primary Systemic

Active, not recruiting
  • Breast Cancer
  • +2 more
  • SLND or TAD by the magnetic technique (SPIO)
  • Uppsala, Sweden
    Uppsala University Hospital
Aug 2, 2023

Breast Cancer Proteomics and Molecular Heterogeneity

Recruiting
  • Primary Breast Cancer
  • Recurrent/Metastatic Breast Cancer
    • Dublin 4, Ireland
    • +1 more
    Jan 14, 2022

    Residual Disease in Breast Cancer Remission After Primary

    Recruiting
    • Breast Cancer
    • minimally invasive preoperative image-guided vacuum-assisted biopsy
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Jul 10, 2023

    Older Women With ER+ Breast Cancer Who Omit Surgery

    Recruiting
    • Breast Cancer
      • Pittsburgh, Pennsylvania
        UPMC Magee Womens Hospital - Surgical Oncology
      Jun 13, 2023

      Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary

      Recruiting
      • Breast Cancer
      • +2 more
      • Systemic therapy for 12 weeks after primary registration
      • +3 more
      • Tokyo, Japan
        Tokyo Medical and Dental Univetsity
      Nov 15, 2023

      Primary Non-metastatic Breast Cancer, Who Remain Disease-free Trial in Lyon, Villejuif (Everolimus, Placebo)

      Active, not recruiting
      • Primary Non-metastatic Breast Cancer
      • Who Remain Disease-free
      • Lyon, France
      • +1 more
      Feb 23, 2022

      Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • LS301-IT 0.025 mg/kg
      • +3 more
      • Scottsdale, Arizona
        Integro Theranostics Research Site #1
      Jun 2, 2023

      Early Breast Cancer Three Years of More Post Primary Treatment

      Recruiting
      • Breast Cancer
      • Exercise Recall Patient Reported Outcomes
      • +10 more
      • Chapel Hill, North Carolina
        University of North Carolina
      Jun 21, 2023